Kevin O’Laughlin

1.8k total citations
13 papers, 146 citations indexed

About

Kevin O’Laughlin is a scholar working on Infectious Diseases, Modeling and Simulation and Molecular Biology. According to data from OpenAlex, Kevin O’Laughlin has authored 13 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Modeling and Simulation and 3 papers in Molecular Biology. Recurrent topics in Kevin O’Laughlin's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 epidemiological studies (4 papers) and Vaccine Coverage and Hesitancy (3 papers). Kevin O’Laughlin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 epidemiological studies (4 papers) and Vaccine Coverage and Hesitancy (3 papers). Kevin O’Laughlin collaborates with scholars based in United States, Australia and Italy. Kevin O’Laughlin's co-authors include Isaac Ghinai, Mark W. Tenforde, Jennifer E. Layden, Anne Kimball, Brooke Hoots, Jennifer Chevinsky, Livia Navon, Lori Saathoff-Huber, Ngozi Ezike and Mark Layer and has published in prestigious journals such as JAMA, PLoS ONE and Emerging infectious diseases.

In The Last Decade

Kevin O’Laughlin

11 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin O’Laughlin United States 7 45 32 29 27 24 13 146
Ellora Karmarkar United States 5 23 0.5× 13 0.4× 19 0.7× 41 1.5× 14 0.6× 15 123
Christine Griesmer United States 3 21 0.5× 105 3.3× 16 0.6× 64 2.4× 31 1.3× 3 199
Zaeema Naveed United States 8 9 0.2× 15 0.5× 17 0.6× 81 3.0× 18 0.8× 24 180
Philip Wikman‐Jorgensen Spain 10 21 0.5× 41 1.3× 48 1.7× 95 3.5× 7 0.3× 29 236
Jude Armishaw Australia 5 31 0.7× 13 0.4× 88 3.0× 60 2.2× 49 2.0× 7 204
John Fardy Canada 8 29 0.6× 25 0.8× 85 2.9× 35 1.3× 2 0.1× 19 282
Andrea Caballero Spain 9 32 0.7× 61 1.9× 79 2.7× 48 1.8× 4 0.2× 29 268
Chiara Montrucchio Italy 9 13 0.3× 23 0.7× 83 2.9× 126 4.7× 63 2.6× 14 211
Michelle Cohen United States 7 19 0.4× 29 0.9× 12 0.4× 52 1.9× 65 2.7× 13 180
A Beyer United States 9 90 2.0× 12 0.4× 85 2.9× 114 4.2× 49 2.0× 22 317

Countries citing papers authored by Kevin O’Laughlin

Since Specialization
Citations

This map shows the geographic impact of Kevin O’Laughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin O’Laughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin O’Laughlin more than expected).

Fields of papers citing papers by Kevin O’Laughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin O’Laughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin O’Laughlin. The network helps show where Kevin O’Laughlin may publish in the future.

Co-authorship network of co-authors of Kevin O’Laughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin O’Laughlin. A scholar is included among the top collaborators of Kevin O’Laughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin O’Laughlin. Kevin O’Laughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Huits, Ralph, et al.. (2025). Measles importations by international travelers, GeoSentinel 2019–2025. Travel Medicine and Infectious Disease. 67. 102885–102885.
2.
Guagliardo, Sarah Anne J., Stacey W. Martin, Carolyn V. Gould, et al.. (2025). Estimation of Incubation Period for Oropouche Virus Disease among Travel-Associated Cases, 2024–2025. Emerging infectious diseases. 31(7). 1337–1343. 1 indexed citations
3.
Atherstone, Christine, Sarah Anne J. Guagliardo, Anthony W. Hawksworth, et al.. (2023). COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021. Emerging infectious diseases. 29(9). 1757–1764. 11 indexed citations
4.
Haston, Julia C., Kevin O’Laughlin, Shantanu Roy, et al.. (2023). The Epidemiology and Clinical Features of Non-Keratitis Acanthamoeba Infections in the United States, 1956–2020. Open Forum Infectious Diseases. 10(1). ofac682–ofac682. 12 indexed citations
5.
O’Laughlin, Kevin, Sarah E. Smith-Jeffcoat, George Khalil, et al.. (2022). Specimen self-collection for SARS-CoV-2 testing: Patient performance and preferences—Atlanta, Georgia, August-October 2020. PLoS ONE. 17(3). e0264085–e0264085. 2 indexed citations
6.
Rodríguez-Nava, Guillermo, Thomas D. Filardo, Joseph D. Cooper, et al.. (2022). Myocarditis Attributable to Monkeypox Virus Infection in 2 Patients, United States, 2022. Emerging infectious diseases. 28(12). 2508–2512. 25 indexed citations
7.
Hawksworth, Anthony W., et al.. (2022). Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions. Emerging infectious diseases. 28(13). S85–S92. 8 indexed citations
8.
Harris, Julie R., Daniel Owusu, Kevin O’Laughlin, et al.. (2022). SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May–June 2021. Emerging infectious diseases. 28(6). 1279–1280. 2 indexed citations
9.
Anjum, Saad, Ibne Karim M. Ali, Jennifer R. Cope, et al.. (2021). A case report of primary amebic meningoencephalitis in North Florida. IDCases. 25. e01208–e01208. 8 indexed citations
10.
Parikh, Sunil, et al.. (2020). Point Prevalence Testing of Residents for SARS-CoV-2 in a Subset of Connecticut Nursing Homes. JAMA. 324(11). 1101–1101. 10 indexed citations
11.
Karp, Beth E., Kaitlin A. Tagg, Jessica Chen, et al.. (2020). 130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States. Open Forum Infectious Diseases. 7(Supplement_1). S195–S195. 3 indexed citations
12.
Ghinai, Isaac, Ian W. Pray, Livia Navon, et al.. (2019). E-cigarette Product Use, or Vaping, Among Persons with Associated Lung Injury — Illinois and Wisconsin, April–September 2019. MMWR Morbidity and Mortality Weekly Report. 68(39). 865–869. 64 indexed citations
13.
McCannon, Bryan C., Kevin O’Laughlin, & Zachary Scott. (2012). The Disincentive of Salary Increases: Evidence from NFL Quarterback Performances. SSRN Electronic Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellora Karmarkar Breakdown of academic impact, for papers by Christine Griesmer Breakdown of academic impact, for papers by Zaeema Naveed Breakdown of academic impact, for papers by Philip Wikman‐Jorgensen Breakdown of academic impact, for papers by Jude Armishaw Breakdown of academic impact, for papers by John Fardy Breakdown of academic impact, for papers by Andrea Caballero Breakdown of academic impact, for papers by Chiara Montrucchio Breakdown of academic impact, for papers by Michelle Cohen Breakdown of academic impact, for papers by A Beyer
Rankless by CCL
2026